CRISPR-Cas-based activation of PPARGC1A boosts endogenous mitochondria and enhances cardiac function after myocardial infarction

Puntos clave

• The research aims to investigate how activating PPARGC1A with CRISPR-Cas can improve heart function following a heart attack.
• Used CRISPR-Cas technology to activate PPARGC1A
• Assessed changes in mitochondrial function
• Evaluated cardiac performance post-myocardial infarction
• Activation of PPARGC1A significantly increased mitochondrial density
• Enhanced cardiac function was observed after treatment
• Improvement in heart recovery metrics was reported post-infarction